Clinical Trial

Long-term of Remote Ischemic Preconditioning and Mindfulness in Patients With Mild Hypertension

Recruiting
View on ClinicalTrials.gov →
Summary
According to the latest survey data of China hypertension annual meeting, there are about 300 million patients with hypertension in China, with 10 million new cases of hypertension each year, and there is an obvious trend of younger people. In particular, young and middle-aged people are in a state of mild hypertension for a long time, which causes great pressure on health and medical treatment. At present, the main clinical measures for mild hypertension are to change their eating habits, quit smoking and alcohol, exercise and other lifestyle changes, as well as drug control. For most patients with mild hypertension, drug control is not the best choice. It has been reported that remote ischemic preconditioning (RIPC) may play an effective role in reducing blood pressure .The purpose of this study was to investigate the extent of long-term application of RIPC to reduce blood pressure in patients with mild hypertension.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-02-10; most recent amendment 2026-04-01.
Status change: Not Yet Recruiting → Recruiting 2021-08-30
Trial Details
NCT Number NCT04753840
Lead Sponsor Henan Institute of Cardiovascular Epidemiology
Conditions Hypertension
Enrollment 400 participants
Start Date 2021-07-03
Primary Completion 2026-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-06